Perceptive Advisors’s RAPT Therapeutics RAPT Stock Holding History

Perceptive Advisors’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,625	Closed	-$83K	–	153
2021 Q2	$83K	Buy	+5,625	New	+$1.05M	﹤0.01%	150

Perceptive Advisors's RAPT Position: Q1 2026 in Review

Perceptive Advisors sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 825,890 shares — an estimated $28M sold.

Perceptive Advisors first reported a position in RAPT in Q4 2020 and held it in 19 quarters. The position peaked at $108M in Q4 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Perceptive Advisors reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Perceptive Advisors sold 825,890 RAPT Therapeutics shares in Q1 2026, an estimated $28M.
Perceptive Advisors first reported a position in RAPT Therapeutics in Q4 2020 and held it in 19 quarters.
Perceptive Advisors's RAPT Therapeutics position peaked at $108M in Q4 2021.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.